The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
| | |
PRELIMINARY PROSPECTUS | | SUBJECT TO COMPLETION, DATED SEPTEMBER 20, 2021 |
$300,000,000
Marblegate Acquisition Corp.
30,000,000 Units
Marblegate Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target regarding a business combination with our company.
This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as described herein. Only whole warrants are exercisable. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination or 12 months from the closing of this offering, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation, as described in this prospectus. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The underwriters have a 45-day option from the date of this prospectus to purchase up to an additional 4,500,000 units to cover over-allotments, if any. We will provide our public stockholders with the opportunity to redeem all or a portion of their shares of our Class A common stock upon the completion of our initial business combination, subject to the limitations described herein. If we are unable to complete our initial business combination within 15 months from the closing of this offering, we will redeem 100% of the public shares for cash, subject to applicable law and certain conditions as further described herein.
Our sponsor, Marblegate Acquisition LLC, and Cantor Fitzgerald & Co., the representative of the underwriters, which we refer to as Cantor, have agreed to purchase an aggregate of 910,000 (or up to 932,500 depending on the extent to which the underwriters’ over-allotment option is exercised) private placement units at a price of $10.00 per unit, for an aggregate purchase price of $9,100,000 (or up to $9,325,000 depending on the extent to which the underwriters’ over-allotment option is exercised), in a private placement that will close simultaneously with the closing of this offering. The private placement units are identical to the units sold in this offering, subject to certain limited exceptions as described in this prospectus.
Up to 18 qualified institutional buyers or institutional accredited investors which are not affiliated with us, our sponsor, our directors or any member of our management, and which we refer to as the anchor investors throughout this prospectus, have each expressed to us an interest in purchasing units in this offering (with up to 11 of these anchor investors each having expressed to us an interest in purchasing up to 1,470,000 units in this offering, up to 5 of these anchor investors each having expressed to us an interest in purchasing up to 2,970,000 units in this offering, and up to 2 of these anchor investors each having expressed to us an interest in purchasing up to 750,000 units in this offering) at the offering price of $10.00, and such allocations will be determined by the underwriters. There can be no assurance that the anchor investors will acquire any units in this offering, or as to the amount of such units the anchor investors will retain, if any, prior to or upon the consummation of our initial business combination. There is also no guarantee that all 18 anchor investors will participate in the offering. Subject to each anchor investor purchasing 100% of the units allocated to it, in connection with the closing of this offering our sponsor will sell up to an aggregate of 2,475,000 founder shares (112,500 founder shares to each anchor investor that has expressed an interest in purchasing up to 1,470,000 units, 225,000 founder shares to each anchor investor that has expressed an interest in purchasing up to 2,970,000 units, and 56,250 founder shares to each anchor investor that has expressed an interest in purchasing up to 750,000 units) to the anchor investors at their original purchase price of approximately $0.002 per share. For a discussion of certain additional arrangements with the anchor investors, see “Summary — The Offering — Expressions of Interest.”
Our initial stockholders, which include our sponsor, own an aggregate of 11,810,833 shares of our Class B common stock (up to 1,507,500 shares of which are subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over-allotment option is exercised), which will automatically convert into shares of Class A common stock at the time of our initial business combination as described herein.
Currently, there is no public market for our units, Class A common stock or warrants. We have applied to list our units on The Nasdaq Global Market, or Nasdaq, under the symbol “GATEU”. We expect that our units will be listed on Nasdaq on or promptly after the date of this prospectus. We cannot guarantee that our securities will be approved for listing on Nasdaq. We expect the Class A common stock and warrants comprising the units will begin separate trading on the 52nd day following the date of this prospectus unless Cantor informs us of its decision to allow earlier separate trading, subject to our satisfaction of certain conditions. Once the securities comprising the units begin separate trading, we expect that the Class A common stock and warrants will be listed on Nasdaq under the symbols “GATE” and “GATEW” respectively.
We are an “emerging growth company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “Risk Factors ” beginning on page 39 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.
Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | | | | | |
| | Per Unit | | | Total | |
Public offering price | | $ | 10.00 | | | $ | 300,000,000 | |
Underwriting discounts and commissions(1) | | $ | 0.70 | | | $ | 21,000,000 | |
Proceeds, before expenses, to Marblegate Acquisition Corp. | | $ | 9.30 | | | $ | 279,000,000 | |
(1) | Includes $0.50 per unit, or $15,000,000 (or up to $18,150,000 if the underwriters’ over-allotment option is exercised in full) in the aggregate payable to Cantor for deferred underwriting commissions which will be placed in a trust account located in the United States as described herein. If the underwriters’ over-allotment option is exercised, 7.0% of the gross proceeds from the over-allotment ($0.70 per unit or up to $3,150,000 in the aggregate) will be deposited in the trust account as deferred underwriting commissions. The deferred commissions will be released to Cantor only upon completion of an initial business combination, as described in this prospectus. Does not include certain other fees and expenses payable to the underwriters in connection with this offering. See the section of this prospectus entitled “Underwriting” beginning on page 170 for a description of compensation and other items of value payable to the underwriters. |
Of the proceeds we receive from this offering and the sale of the private placement units described in this prospectus, $301,500,000 million or $346,725,000 if the underwriters’ over-allotment option is exercised in full ($10.05 per unit in either case) will be initially deposited into a trust account in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and $1,600,000 will be available to pay fees and expenses in connection with the closing of this offering and for working capital following the closing of this offering. The proceeds deposited in the trust account could become subject to the claims of our creditors, if any, which could have priority over the claims of our public stockholders.
The underwriters are offering the units for sale on a firm commitment basis. The underwriters expect to deliver the units to the purchasers on or about , 2021.
Sole Book-Running Manager
Cantor
, 2021